News
HOME  keyboard_arrow_right  News  keyboard_arrow_right  Products  keyboard_arrow_right  A New Solution for the Deficiency of Biospecimens! An Introduction for Clinical Human Biospecimens【BocaBiolistics】
Products
2022/10/24
A New Solution for the Deficiency of Biospecimens! An Introduction for Clinical Human Biospecimens【BocaBiolistics】

In recent years, the research and industries of precision medicine have grown vigorously. Scientists investigate the specific biomarkers for diseases by scrutinizing in vitro/ in vivo biological signals, and combining those profiles with the patients’ lifestyle data and clinical data in order to develop products for personalized treatment and disease prevention. Therefore, the demand for a large amount of clinical human biospecimens and their diverse testing information increased greatly. Besides collecting biospecimens from hospitals, purchasing commercial human biospecimens would be another good option!

 

BocaBiolistics, represented by Mitek, is a company that combines biobanks, clinical research services, and CLIA laboratory testing services. The total number of specimens from BocaBiolistics is over 500,000, originating from 5 continents, and more than 5 million data is stored in the library. Also, the laboratory has obtained CLIA, CAP, and ISO 13485 certifications. Abundant disease specimens and testing items are provided, including cancer, infectious disease (such as COVID-19), tropical disease, gastrointestinal diseases, cardiovascular diseases, neurodegenerative diseases, and so on. In addition, customized specimen collection can also be provided to meet your study requirements!

 

BocaBiolistics has rich experience in collecting and testing cancer biospecimens. Also, it can provide lots of clinical data from those specimens. There are a variety of cancer types (e.g., colorectal cancer, lung cancer, breast cancer, liver cancer, and oral cancer) and matrix types (e.g., plasma, serum, whole blood, and tissue) you can choose from. It also serves information value-added services (e.g., hepatitis C, hepatitis B, HIV, syphilis, ACVR2A, BTBD7, DID07, DIDO1, and microsatellite).

 

BocaBiolistics collaborates with internationally renowned pharmaceutical companies and testing service companies. During the outbreak of the Covid-19 pandemic, BocaBiolistics was also recommended by the US Food and Drug Administration (FDA), making it a unique partner in the field of in vitro diagnostic platforms and drug development industries. BocaBiolistics allows you to obtain human biospecimens efficiently without IRB application, cutting down research budgets, and being more feasible to meet the qualification of EUA and 510(K) approval.

 

If you are interested in BocaBiolistics human biospecimens or testing services, please contact Mitek without hesitation and we will give you the more detailed information.